Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

40.620
-3.580-8.10%
Volume:18.78M
Turnover:777.40M
Market Cap:23.64B
PE:-9.07
High:44.500
Open:43.560
Low:40.260
Close:44.200
52wk High:80.900
52wk Low:29.980
Shares:582.00M
HK Float Shares:582.00M
Volume Ratio:1.02
T/O Rate:3.23%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-4.480
ROE:--
ROA:-11.83%
PB:6.67
PE(LYR):-9.07
PS:53.61

Loading ...

INSILICO issues positive profit warning, forecasting a swing to USD33.50–39.50 million H1 2026 profit on revenue surge to over USD100 million

Bulletin Express
·
Jul 09

Insilico Projects Significant Turnaround with Profit Forecast for First Half of 2026

Stock News
·
Jul 09

Insilico Medicine Cayman Topco - Expects H1 2026 Revenue of Usd102.5 Mln-usd106.5 Mln, up 272.7%-287.3% Y/Y

THOMSON REUTERS
·
Jul 09

Insilico Medicine Expects H1 2026 Net Profit of USD 33.5 Million-usd 39.5 Million

Reuters
·
Jul 09

Insilico Medicine Begins Phase 3 Trial of Lung Disease Drug; Shares Up 3%

MT Newswires Live
·
Jul 08

Movement Alert|Insilico Medicine Rises 5.16% in Regular Trading, First AI-Discovered Drug Rentosertib Enters Phase III Clinical Trial

Market Focus
·
Jul 08

Insilico Commences Phase 3 Trial for Rentosertib

Stock News
·
Jul 08

Insilico Medicine Initiates Phase III Trial of IPF Drug Rentosertib

Reuters
·
Jul 07

Insilico Initiates Phase Iii Clinical Trial for Rentosertib, Its Ai-empowered Tnik Inhibitor for Idiopathic Pulmonary Fibrosis

THOMSON REUTERS
·
Jul 07

Movement Alert|Insilico Medicine Falls 5.11% in Regular Trading, Takeda Deal Gains Fully Priced In Amid Continued Lock-Up Selling Pressure

Market Focus
·
Jul 07

INSILICO expands share capital by 0.53% through option exercises and award vesting

Bulletin Express
·
Jul 06

Insilico Medicine Files HKEX Next-day Disclosure Return, Share Capital Rises by 3,052,484 Shares

Reuters
·
Jul 06

Movement Alert|Insilico Medicine Falls 6.32% in Regular Trading, Post-Takeda Deal Selling Pressure Persists

Market Focus
·
Jul 03

PRESS Digest -wall Street Journal - July 2

Reuters
·
Jul 02

Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery

THOMSON REUTERS
·
Jul 02

Insilico Medicine Cayman Topco: Total Deal Value to Approximately $600 Mln

THOMSON REUTERS
·
Jul 02

Movement Alert|Insilico Medicine Rises 5.81% in Regular Trading, Strategic Collaboration with Takeda Worth Up to $600 Million

Market Focus
·
Jul 02

Insilico Medicine Announces Strategic Collaboration with Takeda for AI-Driven Drug Discovery

Stock News
·
Jul 02

Insilico Medicine and Takeda Sign AI-Driven Drug Discovery Deal Worth up to USD600 million

Bulletin Express
·
Jul 02

Insilico Medicine Cayman Announces Drug Discovery Collaboration with Takeda Worth up to $600 Million

Reuters
·
Jul 02